ICETCR-2026
International Conference on

Emerging Trends in Cancer Research
(ICETCR 2026)

Charting New Paths in Cancer Discovery and Care

April 8, 2026 | Virtual

Welcome Message ICETCR 2026

We are honored to invite you to the International Conference on Emerging Trends in Cancer Research (ICETCR 2026), to be held April 8, 2026 | Virtual


This conference is more than a meeting—it is a premier platform for knowledge exchange, collaboration, and inspiration among leading experts in oncology. Bringing together cancer researchers, clinicians, and innovators from across the globe, ICETCR 2026 presents a comprehensive program centered on groundbreaking scientific advances, collaborative initiatives, and the evolving landscape of cancer care. Together, we will explore the future of cancer research, highlighting the latest developments in diagnostics, therapeutic innovations, and prevention strategies.


ICETCR 2026

Unlock Your Opportunity: Submit, Register, Connect

Step 1

Select Your Focus Area Explore our list of cancer-related themes — including prevention, diagnostics, treatment innovations, survivorship, and more — and choose the topic that aligns with your expertise and interests.

Step 2

Submit Your Abstract Prepare a concise and well-structured abstract outlining your research, clinical case study, or project. Emphasize its relevance, impact, and contribution to the oncology community.

Step 3

Register to Participate Complete your registration to confirm your attendance. Gain full access to all scientific sessions, keynote presentations, panel discussions, workshops, and networking opportunities.

Keynote Speakers
Ajaikumar B. Kunnumakkara
Ajaikumar B. Kunnumakkara

Indian Institute of Technology Guwahati, India

Title: Uncovering Novel Oncogenic Drivers as Therapeutic Targets in Oral Cancer

Kanchugarakoppal S. Rangappa
Kanchugarakoppal S. Rangappa

University of Mysore, India

Title: Development of Small Molecules as Potential Drug Candidates in Cancer Research

Speakers
Derya Ozalp Unal

Central Field Crops Research Institute, Turkey

Title: Investigation of Antiproliferative Effects of Combinations of White and Black Garlic Extracts with 5-Fluorouracil (5-FU) on Caco-2 Colorectal Adenocarcinoma Cells

Niphat Jirapongwattana

University of Nebraska Medical Center, USA

Title: RHNO1-ATR/Chk1 Positive Feedback Loop Sustaining Cellular DNA Replication Stress Response

Shuying Chen

Huashan Hospital, Fudan University, Shanghai, China

Title: RNA Theranostics in Cancer

speakers speakers
speakers
Annu Choudhary

Computational Drug Discovery Researcher, Veer Narmad South Gujarat University, India

Title: Breast Cancer Therapeutics

speakers speakers
speakers
Srimathi Radha

Assistant Professor, Sri Ramachandra Institute of Higher Education & Research, India

Title: QSAR Route to Drug Discovery

speakers speakers
speakers
Kanthlal S K

Professor, Sree Krishna College of Pharmacy and Research Center, India

Title: Synergistic Modulation of PI3K–AKT–mTOR Signaling by Berberine and 5‑Fluorouracil in HCT‑116 Colon Cancer Cells

Aziz Maleki

Zanjan University of Medical Sciences, Iran

Title: Nanostructure-reinforced Multi functional Hydrogels for Synergistic Cancer Therapy

Thamil Selvee Ramasamy

Universiti Malaya, Malaysia

Title: Stem Cell Plasticity in Cancer

Koustav Sarkar

SRM Institute of Science and Technology, India

Title: Involvement of Signal Transducer and Activator of Transcription (STAT) proteins in Epigenetic and Epitranscriptomic Control of T Helper Differentiation in Non-small Cell Lung Cancer (NSCLC) 

Arpana Sharma

Chittaranjan National Cancer Institute, Kolkata, India

Title: SLC7A11 as a Molecular Nexus of Prognosis, Resistance, and Therapeutic Roadmap in Cancer: A Systematic Review and Meta-analysis 

ICETCR 2026

Scientific Sessions

  • Cancer Progression and Prognostic Markers
  • Mechanisms of Cancer Metastasis
  • Cancer Resistance Mechanisms and Overcoming Resistance
  • Tumor Microenvironment and Stromal Interactions
  • The Microbiome–Tumor Axis
  • Early Cancer Detection: Emerging Tools and Strategies
  • Genetic and Epigenetic Biomarkers
  • Circulating Tumor Cells (CTCs) and Circulating Tumor DNA (ctDNA)
  • Artificial Intelligence and Computational Biology in Oncology
  • Precision Oncology and Personalized Therapies
  • Integrative Multi-Omics for Cancer Discovery
  • Liquid Biopsy and Non-Invasive Diagnostic Tools
  • Real-Time Imaging and Monitoring Technologies
  • Novel Drug Development and Clinical Translation
  • Targeted Therapies and Molecular Drug Design
  • Cancer Vaccines: Emerging Platforms and Efficacy
  • Cellular Therapies (CAR-T, TILs, NK Cell Therapy)
  • Radiation Therapy Innovations
  • Breast Cancer: New Frontiers
  • Brain and Central Nervous System Tumors
  • Immunotherapies: Monotherapy and Combination Strategies
  • Non–Small Cell Lung Cancer (NSCLC)
  • Ovarian and Gynecologic Cancers
  • Prostate and Genitourinary Cancers
  • Sarcomas and Soft Tissue Tumors
  • Neuroendocrine Neoplasms
  • Pediatric and Adolescent Cancers
  • Cancer Prevention and Public Health Strategies
  • Survivorship, Quality of Life, and Palliative Care
  • Clinical Trials: Innovations in Design and Access
  • Gastrointestinal Malignancies (Colorectal, Pancreatic, Liver)
  • Equity in Cancer Care and Global Oncology Challenges
ICETCR 2026

Registration Prices

Academic

$109

  • Access to Live Meeting
  • Access to Recorded Talks
  • E-Copy of the Abstract Book
  • Participation E-Certificate
  • Access to Live Discussion
Industry

$149

  • Access to Live Meeting
  • Access to Recorded Talks
  • E-Copy of the Abstract Book
  • Participation E-Certificate
  • Access to Live Discussion
Student

$99

  • Access to Live Meeting
  • Access to Recorded Talks
  • E-Copy of the Abstract Book
  • Participation E-Certificate
  • Access to Live Discussion

Get In Touch Now